Beta-blockers in the treatment of hypertension: latest data and opinions.
Tsalta
Danai
D
1st Propedeutic Department of Internal Medicine, University of Athens, Laiko Hospital, Athens, Greece.
Anastasakis
Emmanuel
E
Papadogiannis
Dimitrios E
DE
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D019808:Losartan / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D017410:Practice Guidelines as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D049993:Sodium Chloride Symporter Inhibitors; D001262:Atenolol; D019808:Losartan